Over centuries, patent systems around the globe have had to adapt to accommodate changing technologies. In the past few decades, however, the speed of technological advancement has been particularly demanding on global patent systems, requiring them to evolve and adapt to these advanced innovations more efficiently. Research on 3D bioprinting technologies is a case in point. This research effort has escalated across the world in recent times. Preliminary patent searches have indicated that most of the patent applications related to bioprinting are filed in the United States (US), Australia, and Europe. Australia, Europe, and the US could thus be described as ‘3D bioprinting technology hubs,’ justifying the choice of these three jurisdictions for analysis in this book.